HenekaMTCarsonMJKhouryJELandrethGEBrosseronFFeinsteinDLet al
Researchers can request the COA before purchase and verify that the lot number on the COA matches the lot number on the vial received
Yes, clinical trials are investigating GLP-1 receptor agonists for neurodegenerative conditions including Alzheimer's and Parkinson's disease, based on preclinical evidence suggesting potential neuroprotective properties
Konig SA, Siemes H, Blaker F, Boenigk E, Gross-Selbeck G, Hanefeld F, Haas N, Kohler B, Koelfen W, Korinthenberg R, et al .: Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities
Subsequent in vivo work in transected tendon and ligament models has reproduced these findings and added documentation of accelerated collagen deposition, growth-hormone receptor upregulation, and improved biomechanical recovery markers